BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2010049)

  • 1. Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site.
    Aebischer P; Lacy PE; Gerasimidi-Vazeou A; Hauptfeld V
    Diabetes; 1991 Apr; 40(4):482-5. PubMed ID: 2010049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model.
    Goss JA; Nakafusa Y; Finke EH; Flye MW; Lacy PE
    Diabetes; 1994 Jan; 43(1):16-23. PubMed ID: 8262312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of intrasplenic islet xenograft survival.
    Janney CG; Lacy PE; Finke EH; Davie JM
    Am J Pathol; 1982 Apr; 107(1):1-5. PubMed ID: 6801990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha prevents rejection of islet xenografts (rat to mouse).
    Gerasimidi A; Sheehan KC; Schreiber RD; Lacy PE
    Diabetes; 1993 May; 42(5):651-7. PubMed ID: 8482422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful transfer of immune unresponsiveness to concordant rat islet xenografts.
    Goss JA; Flye MW; Lacy PE
    Transplantation; 1996 Jan; 61(1):9-13. PubMed ID: 8560581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune unresponsiveness to concordant islet xenografts by intrahepatic preimmunization and transient immunosuppression.
    Goss JA; Finke EH; Flye MW; Lacy PE
    J Clin Invest; 1994 Mar; 93(3):1312-4. PubMed ID: 8132772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival.
    Ricordi C; Lacy PE; Sterbenz K; Davie JM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8080-4. PubMed ID: 3120184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% O2.
    Lacy PE; Finke EH; Janney CG; Davie JM
    Transplantation; 1982 Jun; 33(6):588-92. PubMed ID: 6808723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transplantation site and culture pretreatment on islet xenograft survival (rat to mouse) in experimental diabetes without immunosuppression of the host.
    Jaeger C; Wöhrle M; Bretzel RG; Federlin K
    Acta Diabetol; 1994 Dec; 31(4):193-7. PubMed ID: 7888689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human islet xenograft survival in diabetic rats. A functional and immunohistochemical study.
    Tze WJ; Tai J; Cheung S
    Transplantation; 1990 Mar; 49(3):502-5. PubMed ID: 2107614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathymic inoculation of donor antigen: an ineffective strategy for prolonging xenograft survival.
    Tran HM; Patel A; Allen RD; O'Connell PJ
    Xenotransplantation; 1999 May; 6(2):147-54. PubMed ID: 10431792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection.
    Chen X; Zhang X; Larson C; Xia G; Kaufman DB
    Transplantation; 2008 May; 85(9):1246-52. PubMed ID: 18475179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse).
    Sullivan FP; Ricordi C; Hauptfeld V; Lacy PE
    Transplantation; 1987 Oct; 44(4):465-8. PubMed ID: 3118518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
    Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
    Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratesticular transplants of islet xenografts (rat to mouse).
    Bobzien B; Yasunami Y; Majercik M; Lacy PE; Davie JM
    Diabetes; 1983 Mar; 32(3):213-6. PubMed ID: 6402406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary nonfunction of islet xenografts in rat recipients results from non-T-cell-mediated immune responses.
    Deng S; Ketchum RJ; Kucher T; Weber M; Naji A; Brayman KL
    Transplant Proc; 1997 May; 29(3):1726-7. PubMed ID: 9142249
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantation of discordant pig islet xenografts in diabetic rats.
    Tze WJ; Tai J; Cheung SS
    Diabetes Res Clin Pract; 1992 Mar; 15(3):197-204. PubMed ID: 1576920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.